Replies to post #86825 on Anavex Life Sciences Corp (AVXL)

[ven69]

https://www.bostonglobe.com/business/2016/12/20/incoming-biogen-ceo-calls-alzheimer-drug-its-top-challenge-and-opportunity/XZxbYZFTOWPiGNKqyIcx9L/story.html

Vounatsos, 55, who joined Biogen as chief commercial officer in April, made it clear he wants to expand Biogen’s roster of drug candidates through partnerships with other drug makers and acquisitions of drug development programs — and, possibly, by buying other companies.

Biogen’s most likely takeover candidates would be mid-size biotechs developing drugs to treat neurological diseases and conditions, such as Parkinson’s or Huntington’s diseases, Syed said. But he also said Vounatsos might surprise by venturing into new areas.